Tyra Biosciences, Inc. TYRA Return on equity
Return on equity at other companies
Other financials
Where this comes from
Calculated from Tyra Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tyra Biosciences, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tyra Biosciences, Inc.'s return on equity?
- Tyra Biosciences, Inc. (TYRA) reported return on equity of -36.9% in Q1 2026.
- How has Tyra Biosciences, Inc.'s return on equity changed year-over-year?
- Tyra Biosciences, Inc.'s return on equity decreased by 36.4% year-over-year, from -27% to -36.9%.
- What is the long-term trend for Tyra Biosciences, Inc.'s return on equity?
- Over 3 years (2022 to 2025), Tyra Biosciences, Inc.'s return on equity has grown at a 26.3% compound annual growth rate (CAGR), from -19.8% to -39.8%.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.